Why Natera’s Prospera could reshape how Eledon measures kidney transplant injury in Phase 3
Natera’s Prospera assay will provide serial molecular graft surveillance in Eledon’s planned Phase 3 tegoprubart study, creating a major test of how diagnostics can strengthen transplant drug development.